Delivery Order SPE2DB20D9226-SPE2DB25FQ56A

Award Date 11/8/24
Potential Completion Date 11/12/24
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D9226
    Indefinite Delivery Contract
  • SPE2DB20D9226-SPE2DB25FQ56A
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,622.72 firm fixed-price delivery order is for the supply of 4,566,381,528 units of the prescription drug Xtandi 40 mg capsules. The award is not associated with any set-aside designations.

DMS Pharmaceutical Group holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This delivery order is issued under that larger IDC contract vehicle, which covers branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories.

Generated 2/7/25, 9:21 AM